Principal Financial Group
AVNR

Principal Financial Group’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Principal Financial Group’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-35,890
Closed -$608K – 2249
2014
Q4 		$608K Buy
35,890
+3,904
+12% +$54.9K ﹤0.01% 1857
2014
Q3 		$381K Sell
31,986
-1,237
-4% -$8.45K ﹤0.01% 1878
2014
Q2 		$187K Sell
33,223
-39,751
-54% -$183K ﹤0.01% 2107
2014
Q1 		$268K Sell
72,974
-692
-0.9% -$2.64K ﹤0.01% 2029
2013
Q4 		$248K Buy
73,666
+3,595
+5% +$14.8K ﹤0.01% 2070
2013
Q3 		$297K Buy
70,071
+27,512
+65% +$130K ﹤0.01% 1965
2013
Q2 		$196K Buy
+42,559
New +$146K ﹤0.01% 2092

Principal Financial Group's AVNR Position: Q1 2015 in Review

Principal Financial Group sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 35,890 shares — an estimated $608K sold.

Principal Financial Group first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $608K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Principal Financial Group reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Principal Financial Group sold 35,890 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $608K.
  • Principal Financial Group first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Principal Financial Group's AVANIR PHARMACEUTICALS, INC CL A position peaked at $608K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Principal Financial Group's 13F filing for Q1 2015, filed 12 May 2015.